Expression profiling of tumor cells from MYCN-driven neuroblastoma upon BRD4 or AURKA inhibition
Transcriptomics Dataset
FAIR Metrics
0 evaluations
General Information
| Accession | GSE57810 |
| Title | Expression profiling of tumor cells from MYCN-driven neuroblastoma upon BRD4 or AURKA inhibition |
| Description | Amplification of MYCN is the most prominent genetic marker of high-stage neuroblastoma, a childhood tumor originating from the neural crest. We generated a cell line (mNB-A1) from tumors developed in transgenic mouse and treated these cells with DMSO (n=6), the BRD4-inhibitor JQ1 (n=3) or the AURKA-inhibitor MLN8237 (n=3) for 24 h. |
| Landing Page | https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE57810 |
| Repository | Gene Expression Omnibus |
Tools
used to analyze the dataset
Canned Analyses
generated with the dataset
FAIR Evaluation
Sorry, you must be signed in to evaluate this object.
